4.5 Article

Factors associated with fears due to COVID-19: A Scleroderma Patient-centered Intervention Network (SPIN) COVID-19 cohort study

Journal

JOURNAL OF PSYCHOSOMATIC RESEARCH
Volume 140, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychores.2020.110314

Keywords

Anxiety; Chronic medical condition; COVID-19; Fear; Mental health; Scleroderma; Systemic sclerosis

Categories

Funding

  1. Canadian Institutes of Health Research [VR4-172745]
  2. McGill Interdisciplinary Initiative in Infection and Immunity Emergency COVID-19 Research Fund
  3. Scleroderma Canada
  4. Boehringer Ingelheim
  5. Scleroderma Society of Ontario
  6. Scleroderma Manitoba
  7. Scleroderma Atlantic
  8. Scleroderma Australia
  9. Scleroderma New South Wales
  10. Scleroderma Victoria
  11. Scleroderma Queensland
  12. Scleroderma SASK
  13. Scleroderma Association of BC
  14. Sclerodermie Quebec
  15. Canadian Institutes of Health Research
  16. Arthritis Society
  17. Lady Davis Institute for Medical Research of the Jewish General Hospital, Montreal, Canada
  18. Jewish General Hospital Foundation, Montreal, Canada
  19. McGill University, Montreal, Canada
  20. Fonds de recherche du Quebec - Sante (FRQ-S) postdoctoral fellowship award
  21. Mitacs postdoctoral fellowship award
  22. CIHR Canada Graduate Scholarship Master's award
  23. FRQ-S
  24. Tier 1 Canada Research Chair

Ask authors/readers for more resources

Factors associated with fear of consequences of COVID-19 among people living with systemic sclerosis (SSc) included the degree of interference from breathing problems and adequacy of financial resources. Interventions for this chronically ill population may benefit from addressing specific clinical issues and considering financial resources and political influences.
Introduction: No studies have examined factors associated with fear in any group of people vulnerable during COVID-19 due to pre-existing medical conditions. Objective: To investigate factors associated with fear of consequences of COVID-19 among people living with a pre-existing medical condition, the autoimmune disease systemic sclerosis (SSc; scleroderma), including country. Methods: Pre-COVID-19 data from the Scleroderma Patient-centered Intervention Network (SPIN) Cohort were linked to COVID-19 data collected in April 2020. Multivariable linear regression was used to assess factors associated with continuous scores of the 10-item COVID-19 Fears Questionnaire for Chronic Medical Conditions, controlling for pre-COVID-19 anxiety symptoms. Results: Compared to France (N = 156), COVID-19 Fear scores among participants from the United Kingdom (N = 50) were 0.12 SD (95% CI 0.03 to 0.21) higher; scores for Canada (N = 97) and the United States (N = 128) were higher, but not statistically significant. Greater interference of breathing problems was associated with higher fears due to COVID-19 (Standardized regression coefficient = 0.12, 95% CI 0.01 to 0.23). Participants with higher financial resources adequacy scores had lower COVID-19 Fear scores (Standardized coefficient = -0.18, 95% CI -0.28 to -0.09). Conclusions: Fears due to COVID-19 were associated with clinical and functional vulnerabilities in this chronically ill population. This suggests that interventions may benefit from addressing specific clinical issues that apply to specific populations. Financial resources, health policies and political influences may also be important. The needs of people living with chronic illness during a pandemic may differ depending on the social and political context in which they live.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available